222 related articles for article (PubMed ID: 23991406)
1. The role of skeletal muscle in development of nonalcoholic Fatty liver disease.
Moon JS; Yoon JS; Won KC; Lee HW
Diabetes Metab J; 2013 Aug; 37(4):278-85. PubMed ID: 23991406
[TBL] [Abstract][Full Text] [Related]
2. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.
Xing M; Ni Y; Zhang Y; Zhao X; Yu X
Front Nutr; 2023; 10():1246157. PubMed ID: 38024359
[TBL] [Abstract][Full Text] [Related]
3. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease.
Chen LY; Xia MF; Wu L; Li Q; Hu Y; Ma H; Gao X; Lin HD
World J Diabetes; 2021 Dec; 12(12):2119-2129. PubMed ID: 35047125
[TBL] [Abstract][Full Text] [Related]
5. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
6. The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass.
Choe EK; Kang HY; Park B; Yang JI; Kim JS
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274215
[TBL] [Abstract][Full Text] [Related]
7. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Mai Z; Chen Y; Mao H; Wang L
J Diabetes; 2024 Jun; 16(6):e13569. PubMed ID: 38751375
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity.
Lu Y; Xia Q; Wu L; Xie Z
Front Nutr; 2023; 10():1026054. PubMed ID: 36713086
[TBL] [Abstract][Full Text] [Related]
11. Fatty Liver Index and Skeletal Muscle Density.
Pasco JA; Sui SX; West EC; Anderson KB; Rufus-Membere P; Tembo MC; Hyde NK; Williams LJ; Liu ZSJ; Kotowicz MA
Calcif Tissue Int; 2022 Jun; 110(6):649-657. PubMed ID: 35028685
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease.
Chung GE; Kim MJ; Yim JY; Kim JS; Yoon JW
J Obes Metab Syndr; 2019 Jun; 28(2):129-138. PubMed ID: 31294345
[TBL] [Abstract][Full Text] [Related]
14. Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects.
Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Lenzi A; Donini LM
PLoS One; 2016; 11(1):e0145811. PubMed ID: 26741958
[TBL] [Abstract][Full Text] [Related]
15. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
16. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
[TBL] [Abstract][Full Text] [Related]
17. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease.
Hsieh YC; Joo SK; Koo BK; Lin HC; Kim W
Liver Int; 2021 Mar; 41(3):494-504. PubMed ID: 33164304
[TBL] [Abstract][Full Text] [Related]
18. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011.
Khang AR; Lee HW; Yi D; Kang YH; Son SM
Diabetes Metab Syndr Obes; 2019; 12():181-190. PubMed ID: 30774403
[TBL] [Abstract][Full Text] [Related]
19. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
Giorda C; Forlani G; Manti R; Mazzella N; De Cosmo S; Rossi MC; Nicolucci A; Russo G; Di Bartolo P; Ceriello A; Guida P;
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032449
[TBL] [Abstract][Full Text] [Related]
20. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.
Koehler EM; Schouten JN; Hansen BE; Hofman A; Stricker BH; Janssen HL
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1201-4. PubMed ID: 23353640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
